Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Pharma & Healthcare > Oral Rabies Vaccine - Global Market Insights and Sales Trends 2024

Oral Rabies Vaccine - Global Market Insights and Sales Trends 2024

Oral Rabies Vaccine - Global Market Insights and Sales Trends 2024

Industry: Pharma & Healthcare

Published: 2023-12-29

Pages: 74 Pages

Report ld: 2103831

申请样本

Request Sample

定制报告

Pre-Order Enquiry

  • Description 选中
  • Table of Contents 选中
  • Table of Figures 选中
  • Related Reports 选中
  • PDFPDF Download选中
  • Description 选中
  • Table of Contents 选中
  • Table of Figures 选中
  • Related Reports 选中
  • PDFPDF Download选中

Description

The global Oral Rabies Vaccine market size is expected to reach US$ 297 million by 2029, growing at a CAGR of 20.3% from 2023 to 2029. The market is mainly driven by the significant applications of Oral Rabies Vaccine in various end use industries. The expanding demands from the Government and Commercial, are propelling Oral Rabies Vaccine market. Modified Live Virus, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant Vaccinia segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Oral Rabies Vaccine Market Size(US$)

M= millions and B=billions

QYRLogo
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Rabies Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:
This report provides in-depth analysis of the global Oral Rabies Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Oral Rabies Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Rabies Vaccine sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Oral Rabies Vaccine covered in this report include Boehringer Ingelheim(Merial), Ceva Santé Animale(Artemis Technologies) and Virbac, etc.

The global Oral Rabies Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Oral Rabies Vaccine - Global Market Insights and Sales Trends 2024

  • Forecasted Market Size in 2029

  • US$ 297 million

  • CAGR(2023-2029)

  • 20.3%

  • Market Size Available for Years

  • 2023-2029

  • Global Oral Rabies Vaccine Companies Covered

  • Boehringer Ingelheim(Merial)

    Ceva Santé Animale(Artemis Technologies)

    Virbac

  • Global Oral Rabies Vaccine Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Oral Rabies Vaccine Market, Segment by Type

  • Modified Live Virus

    Recombinant Vaccinia

    Recombinant Adenovirus Vaccine

  • Global Oral Rabies Vaccine Market, Segment by Application

  • Government

    Commercial

  • Forecast Units

  • USD million in value

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oral Rabies Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oral Rabies Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

Table of Contents

1 Oral Rabies Vaccine Market Overview
    1.1 Oral Rabies Vaccine Product Overview
    1.2 Oral Rabies Vaccine Market Segment by Type
        1.2.1 Modified Live Virus
        1.2.2 Recombinant Vaccinia
        1.2.3 Recombinant Adenovirus Vaccine
    1.3 Global Oral Rabies Vaccine Market Size by Type
        1.3.1 Global Oral Rabies Vaccine Market Size Overview by Type (2018-2029)
        1.3.2 Global Oral Rabies Vaccine Historic Market Size Review by Type (2018-2023)
        1.3.3 Global Oral Rabies Vaccine Forecasted Market Size by Type (2024-2029)
    1.4 Key Regions Market Size Segment by Type
        1.4.1 North America Oral Rabies Vaccine Sales Breakdown by Type (2018-2023)
        1.4.2 Europe Oral Rabies Vaccine Sales Breakdown by Type (2018-2023)
        1.4.3 Asia-Pacific Oral Rabies Vaccine Sales Breakdown by Type (2018-2023)
        1.4.4 Latin America Oral Rabies Vaccine Sales Breakdown by Type (2018-2023)
        1.4.5 Middle East and Africa Oral Rabies Vaccine Sales Breakdown by Type (2018-2023)
2 Global Oral Rabies Vaccine Market Competition by Company
    2.1 Global Top Players by Oral Rabies Vaccine Sales (2018-2023)
    2.2 Global Top Players by Oral Rabies Vaccine Revenue (2018-2023)
    2.3 Global Top Players by Oral Rabies Vaccine Price (2018-2023)
    2.4 Global Top Manufacturers Oral Rabies Vaccine Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Oral Rabies Vaccine Market Competitive Situation and Trends
        2.5.1 Oral Rabies Vaccine Market Concentration Rate (2018-2023)
        2.5.2 Global 5 and 10 Largest Manufacturers by Oral Rabies Vaccine Sales and Revenue in 2022
    2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Rabies Vaccine as of 2022)
    2.7 Date of Key Manufacturers Enter into Oral Rabies Vaccine Market
    2.8 Key Manufacturers Oral Rabies Vaccine Product Offered
    2.9 Mergers & Acquisitions, Expansion
3 Oral Rabies Vaccine Status and Outlook by Region
    3.1 Global Oral Rabies Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
    3.2 Global Oral Rabies Vaccine Historic Market Size by Region
        3.2.1 Global Oral Rabies Vaccine Sales in Volume by Region (2018-2023)
        3.2.2 Global Oral Rabies Vaccine Sales in Value by Region (2018-2023)
        3.2.3 Global Oral Rabies Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
    3.3 Global Oral Rabies Vaccine Forecasted Market Size by Region
        3.3.1 Global Oral Rabies Vaccine Sales in Volume by Region (2024-2029)
        3.3.2 Global Oral Rabies Vaccine Sales in Value by Region (2024-2029)
        3.3.3 Global Oral Rabies Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Oral Rabies Vaccine by Application
    4.1 Oral Rabies Vaccine Market Segment by Application
        4.1.1 Government
        4.1.2 Commercial
    4.2 Global Oral Rabies Vaccine Market Size by Application
        4.2.1 Global Oral Rabies Vaccine Market Size Overview by Application (2018-2029)
        4.2.2 Global Oral Rabies Vaccine Historic Market Size Review by Application (2018-2023)
        4.2.3 Global Oral Rabies Vaccine Forecasted Market Size by Application (2024-2029)
    4.3 Key Regions Market Size Segment by Application
        4.3.1 North America Oral Rabies Vaccine Sales Breakdown by Application (2018-2023)
        4.3.2 Europe Oral Rabies Vaccine Sales Breakdown by Application (2018-2023)
        4.3.3 Asia-Pacific Oral Rabies Vaccine Sales Breakdown by Application (2018-2023)
        4.3.4 Latin America Oral Rabies Vaccine Sales Breakdown by Application (2018-2023)
        4.3.5 Middle East and Africa Oral Rabies Vaccine Sales Breakdown by Application (2018-2023)
5 North America Oral Rabies Vaccine by Country
    5.1 North America Oral Rabies Vaccine Historic Market Size by Country
        5.1.1 North America Oral Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        5.1.2 North America Oral Rabies Vaccine Sales in Volume by Country (2018-2023)
        5.1.3 North America Oral Rabies Vaccine Sales in Value by Country (2018-2023)
    5.2 North America Oral Rabies Vaccine Forecasted Market Size by Country
        5.2.1 North America Oral Rabies Vaccine Sales in Volume by Country (2024-2029)
        5.2.2 North America Oral Rabies Vaccine Sales in Value by Country (2024-2029)
6 Europe Oral Rabies Vaccine by Country
    6.1 Europe Oral Rabies Vaccine Historic Market Size by Country
        6.1.1 Europe Oral Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        6.1.2 Europe Oral Rabies Vaccine Sales in Volume by Country (2018-2023)
        6.1.3 Europe Oral Rabies Vaccine Sales in Value by Country (2018-2023)
    6.2 Europe Oral Rabies Vaccine Forecasted Market Size by Country
        6.2.1 Europe Oral Rabies Vaccine Sales in Volume by Country (2024-2029)
        6.2.2 Europe Oral Rabies Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Oral Rabies Vaccine by Region
    7.1 Asia-Pacific Oral Rabies Vaccine Historic Market Size by Region
        7.1.1 Asia-Pacific Oral Rabies Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
        7.1.2 Asia-Pacific Oral Rabies Vaccine Sales in Volume by Region (2018-2023)
        7.1.3 Asia-Pacific Oral Rabies Vaccine Sales in Value by Region (2018-2023)
    7.2 Asia-Pacific Oral Rabies Vaccine Forecasted Market Size by Region
        7.2.1 Asia-Pacific Oral Rabies Vaccine Sales in Volume by Region (2024-2029)
        7.2.2 Asia-Pacific Oral Rabies Vaccine Sales in Value by Region (2024-2029)
8 Latin America Oral Rabies Vaccine by Country
    8.1 Latin America Oral Rabies Vaccine Historic Market Size by Country
        8.1.1 Latin America Oral Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        8.1.2 Latin America Oral Rabies Vaccine Sales in Volume by Country (2018-2023)
        8.1.3 Latin America Oral Rabies Vaccine Sales in Value by Country (2018-2023)
    8.2 Latin America Oral Rabies Vaccine Forecasted Market Size by Country
        8.2.1 Latin America Oral Rabies Vaccine Sales in Volume by Country (2024-2029)
        8.2.2 Latin America Oral Rabies Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Oral Rabies Vaccine by Country
    9.1 Middle East and Africa Oral Rabies Vaccine Historic Market Size by Country
        9.1.1 Middle East and Africa Oral Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        9.1.2 Middle East and Africa Oral Rabies Vaccine Sales in Volume by Country (2018-2023)
        9.1.3 Middle East and Africa Oral Rabies Vaccine Sales in Value by Country (2018-2023)
    9.2 Middle East and Africa Oral Rabies Vaccine Forecasted Market Size by Country
        9.2.1 Middle East and Africa Oral Rabies Vaccine Sales in Volume by Country (2024-2029)
        9.2.2 Middle East and Africa Oral Rabies Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
    10.1 Boehringer Ingelheim(Merial)
        10.1.1 Boehringer Ingelheim(Merial) Company Information
        10.1.2 Boehringer Ingelheim(Merial) Introduction and Business Overview
        10.1.3 Boehringer Ingelheim(Merial) Oral Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
        10.1.4 Boehringer Ingelheim(Merial) Oral Rabies Vaccine Products Offered
        10.1.5 Boehringer Ingelheim(Merial) Recent Development
    10.2 Ceva Santé Animale(Artemis Technologies)
        10.2.1 Ceva Santé Animale(Artemis Technologies) Company Information
        10.2.2 Ceva Santé Animale(Artemis Technologies) Introduction and Business Overview
        10.2.3 Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
        10.2.4 Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Products Offered
        10.2.5 Ceva Santé Animale(Artemis Technologies) Recent Development
    10.3 Virbac
        10.3.1 Virbac Company Information
        10.3.2 Virbac Introduction and Business Overview
        10.3.3 Virbac Oral Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
        10.3.4 Virbac Oral Rabies Vaccine Products Offered
        10.3.5 Virbac Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
    11.1 Oral Rabies Vaccine Key Raw Materials
        11.1.1 Key Raw Materials
        11.1.2 Key Raw Materials Price
        11.1.3 Raw Materials Key Suppliers
    11.2 Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Oral Rabies Vaccine Industrial Chain Analysis
    11.4 Oral Rabies Vaccine Market Dynamics
        11.4.1 Oral Rabies Vaccine Industry Trends
        11.4.2 Oral Rabies Vaccine Market Drivers
        11.4.3 Oral Rabies Vaccine Market Challenges
        11.4.4 Oral Rabies Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
    12.1 Sales Channel
    12.2 Oral Rabies Vaccine Distributors
    12.3 Oral Rabies Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Major Company of Modified Live Virus
    Table 2. Major Company of Recombinant Vaccinia
    Table 3. Major Company of Recombinant Adenovirus Vaccine
    Table 4. Global Oral Rabies Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 5. Global Oral Rabies Vaccine Sales by Type (2018-2023) & (K Units)
    Table 6. Global Oral Rabies Vaccine Sales Market Share in Volume by Type (2018-2023)
    Table 7. Global Oral Rabies Vaccine Sales by Type (2018-2023) & (US& Million)
    Table 8. Global Oral Rabies Vaccine Market Share in Value by Type (2018-2023)
    Table 9. Global Oral Rabies Vaccine Price by Type (2018-2023) & (US$/Unit)
    Table 10. Global Oral Rabies Vaccine Sales by Type (2024-2029) & (K Units)
    Table 11. Global Oral Rabies Vaccine Sales Market Share in Volume by Type (2024-2029)
    Table 12. Global Oral Rabies Vaccine Sales by Type (2024-2029) & (US$ Million)
    Table 13. Global Oral Rabies Vaccine Sales Market Share in Value by Type (2024-2029)
    Table 14. Global Oral Rabies Vaccine Price by Type (2024-2029) & (US$/Unit)
    Table 15. North America Oral Rabies Vaccine Sales by Type (2018-2023) & (K Units)
    Table 16. North America Oral Rabies Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 17. Europe Oral Rabies Vaccine Sales (K Units) by Type (2018-2023)
    Table 18. Europe Oral Rabies Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 19. Asia-Pacific Oral Rabies Vaccine Sales (K Units) by Type (2018-2023)
    Table 20. Asia-Pacific Oral Rabies Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 21. Latin America Oral Rabies Vaccine Sales (K Units) by Type (2018-2023)
    Table 22. Latin America Oral Rabies Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 23. Middle East and Africa Oral Rabies Vaccine Sales (K Units) by Type (2018-2023)
    Table 24. Middle East and Africa Oral Rabies Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 25. Global Oral Rabies Vaccine Sales by Company (2018-2023) & (K Units)
    Table 26. Global Oral Rabies Vaccine Sales Share by Company (2018-2023)
    Table 27. Global Oral Rabies Vaccine Revenue by Company (2018-2023) & (US$ Million)
    Table 28. Global Oral Rabies Vaccine Revenue Share by Company (2018-2023)
    Table 29. Global Market Oral Rabies Vaccine Price by Company (2018-2023) & (US$/Unit)
    Table 30. Global Oral Rabies Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 31. Global Oral Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Rabies Vaccine as of 2022)
    Table 33. Date of Key Manufacturers Enter into Oral Rabies Vaccine Market
    Table 34. Key Manufacturers Oral Rabies Vaccine Product Type
    Table 35. Mergers & Acquisitions, Expansion Plans
    Table 36. Global Oral Rabies Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Global Oral Rabies Vaccine Sales by Region (2018-2023) & (K Units)
    Table 38. Global Oral Rabies Vaccine Sales Market Share in Volume by Region (2018-2023)
    Table 39. Global Oral Rabies Vaccine Sales by Region (2018-2023) & (US$ Million)
    Table 40. Global Oral Rabies Vaccine Sales Market Share in Value by Region (2018-2023)
    Table 41. Global Oral Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 42. Global Oral Rabies Vaccine Sales by Region (2024-2029) & (K Units)
    Table 43. Global Oral Rabies Vaccine Sales Market Share in Volume by Region (2024-2029)
    Table 44. Global Oral Rabies Vaccine Sales by Region (2024-2029) & (US$ Million)
    Table 45. Global Oral Rabies Vaccine Sales Market Share in Value by Region (2024-2029)
    Table 46. Global Oral Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
    Table 47. Global Oral Rabies Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 48. Global Oral Rabies Vaccine Sales by Application (2018-2023) & (K Units)
    Table 49. Global Oral Rabies Vaccine Sales Market Share in Volume by Application (2018-2023)
    Table 50. Global Oral Rabies Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 51. Global Oral Rabies Vaccine Sales Market Share in Value by Application (2018-2023)
    Table 52. Global Oral Rabies Vaccine Price by Application (2018-2023) & (US$/Unit)
    Table 53. Global Oral Rabies Vaccine Sales by Application (2024-2029) & (K Units)
    Table 54. Global Oral Rabies Vaccine Sales Market Share in Volume by Application (2024-2029)
    Table 55. Global Oral Rabies Vaccine Sales by Application (2024-2029) & (US$ Million)
    Table 56. Global Oral Rabies Vaccine Sales Market Share in Value by Application (2024-2029)
    Table 57. Global Oral Rabies Vaccine Price by Application (2024-2029) & (US$/Unit)
    Table 58. North America Oral Rabies Vaccine Sales by Application (2018-2023) (K Units) 
    Table 59. North America Oral Rabies Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 60. Europe Oral Rabies Vaccine Sales by Application (2018-2023) (K Units) 
    Table 61. Europe Oral Rabies Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 62. Asia-Pacific Oral Rabies Vaccine Sales by Application (2018-2023) (K Units) 
    Table 63. Asia-Pacific Oral Rabies Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 64. Latin America Oral Rabies Vaccine Sales by Application (2018-2023) (K Units) 
    Table 65. Latin America Oral Rabies Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 66. Middle East and Africa Oral Rabies Vaccine Sales by Application (2018-2023) (K Units) 
    Table 67. Middle East and Africa Oral Rabies Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 68. North America Oral Rabies Vaccine Sales by Country (2018-2023) & (K Units)
    Table 69. North America Oral Rabies Vaccine Sales Market Share in Volume by Country (2018-2023)
    Table 70. North America Oral Rabies Vaccine Sales by Country (2018-2023) & (US$ Million)
    Table 71. North America Oral Rabies Vaccine Sales Market Share in Value by Country (2018-2023)
    Table 72. North America Oral Rabies Vaccine Sales by Country (2024-2029) & (K Units)
    Table 73. North America Oral Rabies Vaccine Sales Market Share in Volume by Country (2024-2029)
    Table 74. North America Oral Rabies Vaccine Sales by Country (2024-2029) & (US$ Million)
    Table 75. North America Oral Rabies Vaccine Sales Market Share in Value by Country (2024-2029)
    Table 76. Europe Oral Rabies Vaccine Sales by Country (2018-2023) & (K Units)
    Table 77. Europe Oral Rabies Vaccine Sales Market Share in Volume by Country (2018-2023)
    Table 78. Europe Oral Rabies Vaccine Sales by Country (2018-2023) & (US$ Million)
    Table 79. Europe Oral Rabies Vaccine Sales Market Share in Value by Country (2018-2023)
    Table 80. Europe Oral Rabies Vaccine Sales by Country (2024-2029) & (K Units)
    Table 81. Europe Oral Rabies Vaccine Sales Market Share in Volume by Country (2024-2029)
    Table 82. Europe Oral Rabies Vaccine Sales by Country (2024-2029) & (US$ Million)
    Table 83. Europe Oral Rabies Vaccine Sales Market Share in Value by Country (2024-2029)
    Table 84. Asia-Pacific Oral Rabies Vaccine Sales by Region (2018-2023) & (K Units)
    Table 85. Asia-Pacific Oral Rabies Vaccine Sales Market Share in Volume by Region (2018-2023)
    Table 86. Asia-Pacific Oral Rabies Vaccine Sales by Region (2018-2023) & (US$ Million)
    Table 87. Asia-Pacific Oral Rabies Vaccine Sales Market Share in Value by Region (2018-2023)
    Table 88. Asia-Pacific Oral Rabies Vaccine Sales by Region (2024-2029) & (K Units)
    Table 89. Asia-Pacific Oral Rabies Vaccine Sales Market Share in Volume by Region (2024-2029)
    Table 90. Asia-Pacific Oral Rabies Vaccine Sales by Region (2024-2029) & (US$ Million)
    Table 91. Asia-Pacific Oral Rabies Vaccine Sales Market Share in Value by Region (2024-2029)
    Table 92. Latin America Oral Rabies Vaccine Sales by Country (2018-2023) & (K Units)
    Table 93. Latin America Oral Rabies Vaccine Sales Market Share in Volume by Country (2018-2023)
    Table 94. Latin America Oral Rabies Vaccine Sales by Country (2018-2023) & (US$ Million)
    Table 95. Latin America Oral Rabies Vaccine Sales Market Share in Value by Country (2018-2023)
    Table 96. Latin America Oral Rabies Vaccine Sales by Country (2024-2029) & (K Units)
    Table 97. Latin America Oral Rabies Vaccine Sales Market Share in Volume by Country (2024-2029)
    Table 98. Latin America Oral Rabies Vaccine Sales by Country (2024-2029) & (US$ Million)
    Table 99. Latin America Oral Rabies Vaccine Sales Market Share in Value by Country (2024-2029)
    Table 100. Middle East and Africa Oral Rabies Vaccine Sales by Country (2018-2023) & (K Units)
    Table 101. Middle East and Africa Oral Rabies Vaccine Sales Market Share in Volume by Country (2018-2023)
    Table 102. Middle East and Africa Oral Rabies Vaccine Sales by Country (2018-2023) & (US$ Million)
    Table 103. Middle East and Africa Oral Rabies Vaccine Sales Market Share in Value by Country (2018-2023)
    Table 104. Middle East and Africa Oral Rabies Vaccine Sales by Country (2024-2029) & (K Units)
    Table 105. Middle East and Africa Oral Rabies Vaccine Sales Market Share in Volume by Country (2024-2029)
    Table 106. Middle East and Africa Oral Rabies Vaccine Sales by Country (2024-2029) & (US$ Million)
    Table 107. Middle East and Africa Oral Rabies Vaccine Sales Market Share in Value by Country (2024-2029)
    Table 108. Boehringer Ingelheim(Merial) Company Information
    Table 109. Boehringer Ingelheim(Merial) Introduction and Business Overview
    Table 110. Boehringer Ingelheim(Merial) Oral Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 111. Boehringer Ingelheim(Merial) Oral Rabies Vaccine Product
    Table 112. Boehringer Ingelheim(Merial) Recent Development
    Table 113. Ceva Santé Animale(Artemis Technologies) Company Information
    Table 114. Ceva Santé Animale(Artemis Technologies) Introduction and Business Overview
    Table 115. Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 116. Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Product
    Table 117. Ceva Santé Animale(Artemis Technologies) Recent Development
    Table 118. Virbac Company Information
    Table 119. Virbac Introduction and Business Overview
    Table 120. Virbac Oral Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 121. Virbac Oral Rabies Vaccine Product
    Table 122. Virbac Recent Development
    Table 123. Key Raw Materials Lists
    Table 124. Raw Materials Key Suppliers Lists
    Table 125. Oral Rabies Vaccine Market Trends
    Table 126. Oral Rabies Vaccine Market Drivers
    Table 127. Oral Rabies Vaccine Market Challenges
    Table 128. Oral Rabies Vaccine Market Restraints
    Table 129. Oral Rabies Vaccine Distributors List
    Table 130. Oral Rabies Vaccine Downstream Customers
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oral Rabies Vaccine Product Picture
    Figure 2. Global Oral Rabies Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Oral Rabies Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Oral Rabies Vaccine Sales Status and Outlook (2018-2029) & (K Units)
    Figure 5. Product Picture of Modified Live Virus
    Figure 6. Global Modified Live Virus Sales YoY Growth (2018-2029) & (K Units)
    Figure 7. Product Picture of Recombinant Vaccinia
    Figure 8. Global Recombinant Vaccinia Sales YoY Growth (2018-2029) & (K Units)
    Figure 9. Product Picture of Recombinant Adenovirus Vaccine
    Figure 10. Global Recombinant Adenovirus Vaccine Sales YoY Growth (2018-2029) & (K Units)
    Figure 11. Global Oral Rabies Vaccine Sales by Type (2018-2029) & (US$ Million)
    Figure 12. Global Oral Rabies Vaccine Sales Market Share by Type in 2022 & 2029
    Figure 13. North America Oral Rabies Vaccine Sales Market Share in Volume by Type in 2022
    Figure 14. North America Oral Rabies Vaccine Sales Market Share in Value by Type in 2022
    Figure 15. Europe Oral Rabies Vaccine Sales Market Share in Volume by Type in 2022
    Figure 16. Europe Oral Rabies Vaccine Sales Market Share in Value by Type in 2022
    Figure 17. Asia-Pacific Oral Rabies Vaccine Sales Market Share in Volume by Type in 2022
    Figure 18. Asia-Pacific Oral Rabies Vaccine Sales Market Share in Value by Type in 2022
    Figure 19. Latin America Oral Rabies Vaccine Sales Market Share in Volume by Type in 2022
    Figure 20. Latin America Oral Rabies Vaccine Sales Market Share in Value by Type in 2022
    Figure 21. Middle East and Africa Oral Rabies Vaccine Sales Market Share in Volume by Type in 2022
    Figure 22. Middle East and Africa Oral Rabies Vaccine Sales Market Share in Value by Type in 2022
    Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Rabies Vaccine Sales in 2022
    Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Rabies Vaccine Revenue in 2022
    Figure 25. Oral Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 26. Product Picture of Government
    Figure 27. Global Government Sales YoY Growth (2018-2029) & (K Units)
    Figure 28. Product Picture of Commercial
    Figure 29. Global Commercial Sales YoY Growth (2018-2029) & (K Units)
    Figure 30. Global Oral Rabies Vaccine Sales by Application (2018-2029) & (US$ Million)
    Figure 31. Global Oral Rabies Vaccine Sales Market Share by Application in 2022 & 2029
    Figure 32. North America Oral Rabies Vaccine Sales Market Share in Volume by Application in 2022
    Figure 33. North America Oral Rabies Vaccine Sales Market Share in Value by Application in 2022
    Figure 34. Europe Oral Rabies Vaccine Sales Market Share in Volume by Application in 2022
    Figure 35. Europe Oral Rabies Vaccine Sales Market Share in Value by Application in 2022
    Figure 36. Asia-Pacific Oral Rabies Vaccine Sales Market Share in Volume by Application in 2022
    Figure 37. Asia-Pacific Oral Rabies Vaccine Sales Market Share in Value by Application in 2022
    Figure 38. Latin America Oral Rabies Vaccine Sales Market Share in Volume by Application in 2022
    Figure 39. Latin America Oral Rabies Vaccine Sales Market Share in Value by Application in 2022
    Figure 40. Middle East and Africa Oral Rabies Vaccine Sales Market Share in Value by Application in 2022
    Figure 41. Key Raw Materials Price
    Figure 42. Oral Rabies Vaccine Manufacturing Cost Structure
    Figure 43. Oral Rabies Vaccine Industrial Chain Analysis
    Figure 44. Channels of Distribution
    Figure 45. Distributors Profiles
    Figure 46. Bottom-up and Top-down Approaches for This Report
    Figure 47. Data Triangulation
    Figure 48. Key Executives Interviewed

Description

The global Oral Rabies Vaccine market size is expected to reach US$ 297 million by 2029, growing at a CAGR of 20.3% from 2023 to 2029. The market is mainly driven by the significant applications of Oral Rabies Vaccine in various end use industries. The expanding demands from the Government and Commercial, are propelling Oral Rabies Vaccine market. Modified Live Virus, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant Vaccinia segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Rabies Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:
This report provides in-depth analysis of the global Oral Rabies Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Oral Rabies Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Rabies Vaccine sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Oral Rabies Vaccine covered in this report include Boehringer Ingelheim(Merial), Ceva Santé Animale(Artemis Technologies) and Virbac, etc.

The global Oral Rabies Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oral Rabies Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oral Rabies Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

Related Reports

Oral Rabies Vaccine - Global Market Insights and Sales Trends 2024

Industry: Pharma & Healthcare

Published: 2023-12-29

Pages: 74 Pages

Report ld: 2103831

申请样本

Request Sample

定制报告

Pre-Order Enquiry

CHOOSE LICENSE TYPE
提示

USD 3350.00

提示

USD 5025.00

提示

USD 6700.00

加入购物车

Add to Cart

立即购买

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

HITESH

English

English

HITESH

+91-86 6998 6909

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 18 years of vast experience

    More than 18 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

申请样本

Request Sample

定制报告

Pre-Order Enquiry

加入购物车

Add to Cart

立即购买

Buy Now